Optimising pharmacological maintenance treatment for COPD in primary care.
about
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study.Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010.The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis.GOLD guidelines 2011: what are the implications for primary care?Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.Subutilization of COPD guidelines in primary care: a pilot study.Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.Macrolides for macrophages in chronic obstructive pulmonary disease.Co-morbidity is the norm, not the exception: chronic respiratory diseases in chronic drug usersNew developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
P2860
Q34109192-7CFFAFD9-C9F1-4406-A9B6-560840A885BDQ34944547-32E59D83-FDB7-4444-8C91-8D2124076B30Q35153960-64CBCDC1-9652-45CC-8A88-6C9E420ED79BQ38151184-56BF2C7D-01C5-4CED-A4C3-27CD32D6D4ECQ39587692-5996F7FE-E5D0-4A35-B183-774F9A8E3DCEQ41633769-CA3D741F-B1AB-4C36-B83E-F9470678F24BQ42011965-0E0B67F9-17DE-470B-A00D-10B8471D8E94Q46842608-DF2D0CC2-DECB-4594-855F-5EAFD39FA1D9Q50905501-3963C2C8-DCAA-4679-BFD1-C0A016F1F687Q54337018-6746163A-6B13-4E0F-8776-3B6F2413DD0EQ58712547-B6677356-0559-4643-AB9A-2FA844B62BE7Q58759101-088BF0D2-A7B5-4684-BE5C-68BFC86CC9CE
P2860
Optimising pharmacological maintenance treatment for COPD in primary care.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimising pharmacological maintenance treatment for COPD in primary care.
@en
Optimising pharmacological maintenance treatment for COPD in primary care.
@nl
type
label
Optimising pharmacological maintenance treatment for COPD in primary care.
@en
Optimising pharmacological maintenance treatment for COPD in primary care.
@nl
prefLabel
Optimising pharmacological maintenance treatment for COPD in primary care.
@en
Optimising pharmacological maintenance treatment for COPD in primary care.
@nl
P2860
P356
P1476
Optimising pharmacological maintenance treatment for COPD in primary care.
@en
P2093
Anders Østrem
Rupert Jones
P2860
P2888
P356
10.4104/PCRJ.2010.00069
P577
2011-03-01T00:00:00Z
P5875
P6179
1021268096